This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
Adalimumab (Humira) for Crohns Disease . Lansdale: HAYES, Inc.. 2009
Authors' objectives
Adalimumab (D2E7, Humira®; Abbott Laboratories) is a recombinant human immunoglobulin G1 (IgG1) monoclonal antibody that binds with high affinity and specificity to human solu